-
Plenary Session I: Thursday, October 18, 2018
"Improving Outcomes of Infections in the Age of CFTR Modulators"
Speaker: Lisa Saiman, M.D., M.P.H.
In this session, Dr. Lisa Saiman will address the challenges
of infections in people with CF and discuss why infections remain a major focus
of the CF community, even in the era of effective CFTR modulators. She will
provide an overview of CF infections, describe ongoing studies to increase our
understanding of CF microorganisms and their optimal treatment, and discuss
current strategies to develop new anti-infective agents to treat even the most
difficult infections.
-
Plenary Session II: Friday, October 19, 2018
"Anti-inflammatories & Mucociliary Clearance Therapies in the Age of CFTR Modulators"
Speaker: Felix Ratjen, M.D., Ph.D.
This plenary will review the effect of CFTR dysfunction and
CFTR restoration on both inflammation and mucociliary clearance in individuals
with CF. Current and future therapeutic strategies to address inflammation and
mucociliary clearance will be discussed, as well as how these strategies have
potential to benefit both those patients using CFTR modulators and those not
eligible for modulators.
-
Plenary Session III: Saturday, October 20, 2018
"Partnering: The Oldest New Idea to Improve CF Care"
Speakers:
Maren Batalden, M.D., Kathryn Sabadosa, M.P.H., Melanie Abdelnour, Cynthia
George, R.N., M.S.N., F.N.P.
Central
to the management of cystic fibrosis are the relationships that people with CF
and their families build with their clinical care teams. As people with CF live
longer, their disease increases in complexity, making coordination and
individualized care ever more dependent upon these foundational relationships.
Actively partnering in health care is a learning process and although, highly
regarded, realizing and maintaining full partnership can be challenging. This
plenary will walk through the evolution of partnering, specifically in CF care
and more broadly in the context of health care and society, further thinking by
exploring the tensions impacting partnership, and highlight new strategies
supported by the CF Foundation, so that all people living with CF can better
balance their daily care while attaining personal goals. The plenary will end with
a panel discussion between an adult living with CF, a parent, and a healthcare
professional from the CF Foundation.
-
Plenary Session I: Thursday, November 2, 2017
"Matching Medicines With Mutations"
Speakers: Michael P. Boyle, M.D., FCCP and Philip J. Thomas, Ph.D.
Increasing
numbers of people with CF now benefit from disease-altering small molecule
therapies that target the basic defect in CFTR. Use of these therapies
has been extended recently using a combination of in vitro laboratory
experiments to identify responsive mutations, and clinical trials to determine
effect on clinical outcomes. This plenary will summarize how recent advances
may allow in the near future over 90% of individuals with CF to benefit from
therapies that target the basic defect in CFTR, including even those with the
rarest disease causing mutations.
-
Plenary Session III: Saturday, November 4, 2017
"Partnering With the Community"
Speaker: Drucy Borowitz, M.D. and
Mary B. Dwight
This plenary session will focus on
ways people with CF and their families make a difference by partnering with the
larger community as advocates, by sharing their expertise on living life with
CF with their care center teams, and by supporting with each other through
virtual events and peer mentoring.
-
Plenary Session I: Thursday, October 27, 2016
"A Cure for All: Leaving No One Behind"
Speakers: Mitchell Drumm, Ph.D. and Eric Sorscher, M.D.
This session describes recent advances toward treatment of cystic fibrosis and the pipeline for new and emerging therapies.